Combined use of amrinone and high-dose epinephrine for postoperative low output syndrome (LOS) in pediatric patients

1996 ◽  
Vol 10 (1) ◽  
pp. 63-65
Author(s):  
Jun Uehara ◽  
Takerou Fukutome ◽  
Akira Sese
Keyword(s):  
Pediatric Patients ◽  
High Dose ◽  
Low Output Syndrome ◽  
Combined Use

New Therapeutic Approach to Reduce Methotrexate Toxicity after High-Dose Chemotherapy in a Child with Acute Lymphocytic Leukemia: Efficacy and Safety of Hemoadsorption with HA-230 Adsorber

2021 ◽  
pp. 1-5
Author(s):  
Vitaliy Sazonov ◽  
Zaure Tobylbayeva ◽  
Askhat Saparov ◽  
Bolatbek Jubaniyazov ◽  
Samat Issakov ◽  
...  
Keyword(s):  
Acute Lymphocytic Leukemia ◽  
Pediatric Patients ◽  
High Dose Chemotherapy ◽  
The Body ◽  
Lymphocytic Leukemia ◽  
High Dose ◽  
Successful Implementation ◽  
Efficacy And Safety ◽  
Related Complication ◽  
Dose Methotrexate

Background: High-dose methotrexate (HDMTX) is likely to cause a number of side effects and manifest itself as hepatotoxicity, nephrotoxicity, mucositis, and neurotoxicity. A several studies demonstrated the efficacy of extracorporeal detoxification methods such as plasma exchange, hemodialysis (HD), HD filtration, and hemoperfusion for the treatment of MTX delayed clearance. However, none of the existing methods as effective as expected and limited for general implementation due to a procedure-related complication. Case Report: Here, we report a successful implementation of HA-230 hemoadsorption procedure to remove cumulated MTX from the body and reduce its toxicity in a child with ALL after high-dose chemotherapy. Results and Conclusion: Based on our results, single-hemoadsorption procedure with the HA-230 adsorber in case of delayed methotrexate clearance was safe and well-tolerated in a pediatric patient with ALL and would significantly improve the patient’s condition. Further studies need to demonstrate its safety and efficacy in a large number of pediatric patients.

scholarly journals Analgesic Efficacy of a Combination of Fentanyl and a Japanese Herbal Medicine “Yokukansan” in Rats with Acute Inflammatory Pain

Medicines ◽  
2020 ◽  
Vol 7 (12) ◽  
pp. 75
Author(s):  
Yuko Akanuma ◽  
Mami Kato ◽  
Yasunori Takayama ◽  
Hideshi Ikemoto ◽  
Naoki Adachi ◽  
...  
Keyword(s):  
Inflammatory Pain ◽  
Late Phase ◽  
Analgesic Efficacy ◽  
Opioid Tolerance ◽  
High Dose ◽  
Erk Pathway ◽  
Single High Dose ◽  
Extracellular Signal Regulated Kinase ◽  
Extracellular Signal ◽  
Combined Use

Background: Fentanyl can induce acute opioid tolerance and postoperative hyperalgesia when administered at a single high dose; thus, this study examined the analgesic efficacy of a combination of fentanyl and Yokukansan (YKS). Methods: Rats were divided into control, formalin-injected (FOR), YKS-treated+FOR (YKS), fentanyl-treated+FOR (FEN), and YKS+FEN+FOR (YKS+FEN) groups. Acute pain was induced via subcutaneous injection of formalin into the paw. The time engaged in pain-related behavior was measured. Results: In the early (0–10 min) and intermediate (10–20 min) phases, pain-related behavior in the YKS+FEN group was significantly inhibited compared with the FOR group. In the late phase (20–60 min), pain-related behavior in the FEN group was the longest and significantly increased compared with the YKS group. We explored the influence on the extracellular signal-regulated kinase (ERK) pathway in the spinal cord, and YKS suppressed the phosphorylated ERK expression, which may be related to the analgesic effect of YKS in the late phase. Conclusions: These findings suggest that YKS could reduce the use of fentanyl and combined use of YKS and fentanyl is considered clinically useful.

scholarly journals Lacosamide-Induced Dyskinesia in Children With Intractable Epilepsy

2020 ◽  
Vol 35 (10) ◽  
pp. 662-666
Author(s):  
Nadine Madani ◽  
Jennifer A. O’Malley ◽  
Brenda E. Porter ◽  
Fiona M. Baumer
Keyword(s):  
Upper Extremity ◽  
Pediatric Patients ◽  
Focal Epilepsy ◽  
Intractable Epilepsy ◽  
High Dose ◽  
Drug Induced ◽  
Potential Side Effect ◽  
Increased Risk ◽  
The Face ◽  
Dose Dependent

Lacosamide, an antiepileptic drug prescribed for children with refractory focal epilepsy, is generally well tolerated, with dose-dependent adverse effects. We describe 4 children who developed a movement disorder in conjunction with the initiation and/or uptitration of lacosamide. Three patients developed dyskinesias involving the face or upper extremity whereas the fourth had substantial worsening of chronic facial tics. The patients all had histories suggestive of opercular dysfunction: 3 had seizure semiologies including hypersalivation, facial and upper extremity clonus while the fourth underwent resection of polymicrogyria involving the opercula. Onset, severity, and resolution of dyskinesias correlated with lacosamide dosing. These cases suggest that pediatric patients with dysfunction of the opercular cortex are at increased risk for developing drug-induced dyskinesias on high-dose lacosamide therapy. Practitioners should be aware of this potential side effect and consider weaning lacosamide or video electroencephalography (EEG) for differential diagnosis, particularly in pediatric patients with underlying opercular dysfunction.

scholarly journals Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia

2013 ◽  
Vol 61 (5) ◽  
pp. 815-820 ◽  
Author(s):  
Meghann McManus ◽  
Haydar Frangoul ◽  
Jonathan A. McCullers ◽  
Li Wang ◽  
Alice O'Shea ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Influenza Vaccine ◽  
Pediatric Patients ◽  
Lymphoblastic Leukemia ◽  
High Dose
Sign in / Sign up

Export Citation Format

Share Document